Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Common, usually mild: Injection-site reactions (redness, swelling, itching), most frequent with both Mild headache, dizziness, or flushing after injection Initial water retention as IGF-1 rises Transient fatigue in the first 12 weeks Less common, dose-dependent: Carpal tunnel-like wrist symptoms (sign IGF-1 may be too high) Joint discomfort or stiffness Numbness or tingling in extremities Elevated blood glucose (GH antagonizes insulin) The monitoring that matters:IGF-1 (insulin-like growth factor 1, the downstream marker of GH activity) is the lab value that tells you whether youre in a therapeutic range or pushing past it
Recent Advances: BPC 157 has practical applicability (given alone, with the same dose range, and same equipotent routes of application, regardless the injury tested)
It appears to act as a tumor suppressor in some cancers including hepatoma [33] and non-small cell lung cancer [34], where its downregulation in tumor tissue is associated with a worse prognosis
High-fat diet-induced intestinal dysbiosis is associated with the exacerbation of Sjogrens syndrome
US$ 23.81
US$ 25.38
US$ 27.00
US$ 24.81
US$ 28.70
US$ 24.36
US$ 27.95
